Your browser doesn't support javascript.
loading
Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs.
Ferruz, Noelia; Doerr, Stefan; Vanase-Frawley, Michelle A; Zou, Yaozhong; Chen, Xiaomin; Marr, Eric S; Nelson, Robin T; Kormos, Bethany L; Wager, Travis T; Hou, Xinjun; Villalobos, Anabella; Sciabola, Simone; De Fabritiis, Gianni.
Afiliação
  • Ferruz N; Computational Biophysics Laboratory (GRIB-IMIM), Universitat Pompeu Fabra, Barcelona Biomedical Research Park (PRBB), Doctor Aiguader 88, 08003, Barcelona, Spain.
  • Doerr S; Acellera, PRBB, Doctor Aiguader 88, 08003, Barcelona, Spain.
  • Vanase-Frawley MA; Computational Biophysics Laboratory (GRIB-IMIM), Universitat Pompeu Fabra, Barcelona Biomedical Research Park (PRBB), Doctor Aiguader 88, 08003, Barcelona, Spain.
  • Zou Y; Acellera, PRBB, Doctor Aiguader 88, 08003, Barcelona, Spain.
  • Chen X; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut, 06340, United States.
  • Marr ES; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut, 06340, United States.
  • Nelson RT; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut, 06340, United States.
  • Kormos BL; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut, 06340, United States.
  • Wager TT; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut, 06340, United States.
  • Hou X; Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts, 02139, United States.
  • Villalobos A; Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts, 02139, United States.
  • Sciabola S; Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts, 02139, United States.
  • De Fabritiis G; Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts, 02139, United States.
Sci Rep ; 8(1): 897, 2018 01 17.
Article em En | MEDLINE | ID: mdl-29343833
ABSTRACT
The recent increase in the number of X-ray crystal structures of G-protein coupled receptors (GPCRs) has been enabling for structure-based drug design (SBDD) efforts. These structures have revealed that GPCRs are highly dynamic macromolecules whose function is dependent on their intrinsic flexibility. Unfortunately, the use of static structures to understand ligand binding can potentially be misleading, especially in systems with an inherently high degree of conformational flexibility. Here, we show that docking a set of dopamine D3 receptor compounds into the existing eticlopride-bound dopamine D3 receptor (D3R) X-ray crystal structure resulted in poses that were not consistent with results obtained from site-directed mutagenesis experiments. We overcame the limitations of static docking by using large-scale high-throughput molecular dynamics (MD) simulations and Markov state models (MSMs) to determine an alternative pose consistent with the mutation data. The new pose maintains critical interactions observed in the D3R/eticlopride X-ray crystal structure and suggests that a cryptic pocket forms due to the shift of a highly conserved residue, F6.52. Our study highlights the importance of GPCR dynamics to understand ligand binding and provides new opportunities for drug discovery.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Acoplados a Proteínas G / Receptores de Dopamina D3 Limite: Animals / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Acoplados a Proteínas G / Receptores de Dopamina D3 Limite: Animals / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha